Literature DB >> 6039537

The absolute configuration of delta-1-tetrahydrocannabinol, the major active constituent of hashish.

R Mechoulam, Y Gaoni.   

Abstract

Entities:  

Mesh：

Year:  1967        PMID： 6039537     DOI： 10.1016/s0040-4039(00)90646-4

Source DB:  PubMed          Journal:  Tetrahedron Lett        ISSN： 0040-4039            Impact factor:   2.415


× No keyword cloud information.
  46 in total

1.  A survey study to characterize use of Spice products (synthetic cannabinoids).

Authors:  Ryan Vandrey; Kelly E Dunn; Jeannie A Fry; Elizabeth R Girling
Journal:  Drug Alcohol Depend       Date:  2011-08-10       Impact factor: 4.492

Review 2.  Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.

Authors:  Evan C Rosenberg; Pabitra H Patra; Benjamin J Whalley
Journal:  Epilepsy Behav       Date:  2017-02-09       Impact factor: 2.937

3.  Synthesis, ex vivo evaluation, and radiolabeling of potent 1,5-diphenylpyrrolidin-2-one cannabinoid subtype-1 receptor ligands as candidates for in vivo imaging.

Authors:  Sean R Donohue; Joseph H Krushinski; Victor W Pike; Eyassu Chernet; Lee Phebus; Amy K Chesterfield; Christian C Felder; Christer Halldin; John M Schaus
Journal:  J Med Chem       Date:  2008-09-25       Impact factor: 7.446

4.  Themed issue on cannabinoids in biology and medicine.

Authors:  Itai Bab
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

5.  Cannabis constituents modulate δ9-tetrahydrocannabinol-induced hyperphagia in rats.

Authors:  Jonathan A Farrimond; Andrew J Hill; Benjamin J Whalley; Claire M Williams
Journal:  Psychopharmacology (Berl)       Date:  2010-03-27       Impact factor: 4.530

6.  A cannabigerol quinone alleviates neuroinflammation in a chronic model of multiple sclerosis.

Authors:  Aitor G Granja; Francisco Carrillo-Salinas; Alberto Pagani; María Gómez-Cañas; Roberto Negri; Carmen Navarrete; Miriam Mecha; Leyre Mestre; Bend L Fiebich; Irene Cantarero; Marco A Calzado; Maria L Bellido; Javier Fernandez-Ruiz; Giovanni Appendino; Carmen Guaza; Eduardo Muñoz
Journal:  J Neuroimmune Pharmacol       Date:  2012-09-14       Impact factor: 4.147

7.  Novel Drugs of Abuse: A Snapshot of an Evolving Marketplace.

Authors:  Ryan Vandrey; Matthew W Johnson; Patrick S Johnson; Miral A Khalil
Journal:  Adolesc Psychiatry (Hilversum)       Date:  2013-04

8.  Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide.

Authors:  T Bisogno; L Hanus; L De Petrocellis; S Tchilibon; D E Ponde; I Brandi; A S Moriello; J B Davis; R Mechoulam; V Di Marzo
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

9.  Tetrahydrocannabinol (Delta 9-THC) Treatment in Chronic Central Neuropathic Pain and Fibromyalgia Patients: Results of a Multicenter Survey.

Authors:  Janet Weber; Marcus Schley; Matthias Casutt; Helmut Gerber; Guido Schuepfer; Roman Rukwied; Wolfgang Schleinzer; Michael Ueberall; Christoph Konrad
Journal:  Anesthesiol Res Pract       Date:  2009-10-25

Review 10.  Dynamic regulation of the endocannabinoid system: implications for analgesia.

Authors:  Devi Rani Sagar; A Gemma Gaw; Bright N Okine; Stephen G Woodhams; Amy Wong; David A Kendall; Victoria Chapman
Journal:  Mol Pain       Date:  2009-10-08       Impact factor: 3.395
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.